English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Ester Orlandi‡ ,1 & Lisa Licitra*,‡ ,2,3 1Radiotherapy 1–2 Units, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy 2Medical Oncology 3 Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan 20133, Italy 3University of Milan, Milan, Italy *Author for correspondence: Tel.: +39 022 390 3352; Fax: +39 022 390 3769; lisa.licitra@istitutotumori.mi.it ‡Authors contributed equally

The day after De-ESCALaTE and RTOG 1016 trials results